Merck & Co Archives - Pharmaphorum

Neurofibromatosis treatment granted orphan status by EMA

https://pharmaphorum.com/news/nf1-treatment-granted-orphan-status-ema/

EU regulators reject new use for Opdivo, as Keytruda edges ahead

https://pharmaphorum.com/news/eu-regulators-reject-new-use-for-opdivo-as-keytruda-edges-ahead/

BMS immunotherapy combo approved in new colorectal use

https://pharmaphorum.com/news/bms-immunotherapy-combo-approved-in-new-colorectal-use/

Roche to file Tecentriq in triple negative breast cancer

https://pharmaphorum.com/news/roche-files-tecentriq-triple-negative-breast-cancer/

EU regulators back BMS’ Opdivo in new skin cancer use

https://pharmaphorum.com/news/eu-regulators-back-bms-opdivo-in-new-skin-cancer-use/

AstraZeneca/Merck hope for expanded ovarian cancer drug use

https://pharmaphorum.com/news/astrazeneca-mercks-hope-for-expanded-lynparza/

FDA approves Keytruda in cervical cancer

https://pharmaphorum.com/news/fda-approves-keytruda-cervical-cancer/

Merck & Co plans software application to help tackle C. diff infections

https://pharmaphorum.com/news/merck-co-software-c-diff-infections/

Top pharmaceutical companies in the world in 2017

https://pharmaphorum.com/views-and-analysis/top-pharmaceutical-companies-world-2017/

Search